Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 6 studies | 32% ± 15% | |
epithelial cell | 4 studies | 20% ± 3% | |
basal cell | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1871.02 | 245 / 245 | 100% | 9.47 | 502 / 502 |
ovary | 100% | 1548.54 | 180 / 180 | 99% | 8.47 | 426 / 430 |
thymus | 100% | 2665.11 | 653 / 653 | 99% | 10.63 | 599 / 605 |
intestine | 100% | 1313.36 | 966 / 966 | 98% | 7.14 | 519 / 527 |
stomach | 100% | 1123.31 | 359 / 359 | 98% | 6.62 | 280 / 286 |
pancreas | 100% | 1007.95 | 327 / 328 | 97% | 7.97 | 173 / 178 |
bladder | 100% | 1574.00 | 21 / 21 | 97% | 9.81 | 488 / 504 |
breast | 99% | 1118.52 | 456 / 459 | 96% | 6.81 | 1074 / 1118 |
lung | 99% | 1002.44 | 574 / 578 | 95% | 6.41 | 1092 / 1155 |
liver | 99% | 853.54 | 223 / 226 | 93% | 5.08 | 378 / 406 |
uterus | 100% | 1639.61 | 170 / 170 | 90% | 5.92 | 415 / 459 |
kidney | 100% | 1723.75 | 89 / 89 | 89% | 4.91 | 806 / 901 |
skin | 98% | 1072.73 | 1766 / 1809 | 91% | 7.67 | 430 / 472 |
brain | 97% | 619.72 | 2568 / 2642 | 91% | 4.54 | 641 / 705 |
esophagus | 100% | 1113.74 | 1444 / 1445 | 81% | 5.41 | 149 / 183 |
adrenal gland | 100% | 1447.30 | 258 / 258 | 70% | 2.99 | 162 / 230 |
spleen | 100% | 846.73 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.75 | 1 / 1 |
blood vessel | 100% | 1318.91 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 625.70 | 1175 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 890.92 | 883 / 929 | 0% | 0 | 0 / 0 |
muscle | 93% | 512.66 | 747 / 803 | 0% | 0 | 0 / 0 |
heart | 91% | 647.57 | 784 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 2.85 | 35 / 45 |
eye | 0% | 0 | 0 / 0 | 73% | 2.46 | 58 / 80 |
lymph node | 0% | 0 | 0 / 0 | 52% | 1.80 | 15 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
GO_2001311 | Biological process | lysobisphosphatidic acid metabolic process |
GO_0016311 | Biological process | dephosphorylation |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0052642 | Molecular function | lysophosphatidic acid phosphatase activity |
GO_0003993 | Molecular function | acid phosphatase activity |
Gene name | ACP6 |
Protein name | Lysophosphatidic acid phosphatase 6 isoform D Acid phosphatase 6, lysophosphatidic acid phosphatase (EC 3.1.3.2) Lysophosphatidic acid phosphatase type 6 (EC 3.1.3.2) (Acid phosphatase 6, lysophosphatidic) (Acid phosphatase-like protein 1) (PACPL1) |
Synonyms | UNQ205/PRO231 ACPL1 LPAP |
Description | FUNCTION: Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. . |
Accessions | ENST00000493129.2 X5D7V3 A0A087WWB7 X5D319 A0A087WW36 ENST00000611629.4 ENST00000392988.6 Q9NPH0 ENST00000620634.4 V9GZ71 X5D9K6 ENST00000487562.5 [Q9NPH0-2] ENST00000609196.5 A0A087WYU6 A0A0A0MS36 ENST00000583509.7 [Q9NPH0-1] |